# active_site_0128

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `active_site`  
**Author expected answer:** **B** — Position 156 (Acyl-thioester intermediate)

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | reasoning-supported | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | valid_review |

**Paired comparison:** key agree; reasoning agree. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MSPRPQIKVGVLGATGTVGQRFIELLAAHPYFALHALGASSRSAGQQYARVVRWKLPSPIPDAVRHMVVHECRPDAPGFAECGVVFSGLDADVAGDIENAFRAADLVVYSNAKNYRRDPLCPLIVPLVNPSHLSIIPYQREQLGLKKGYIVTNANCSTTGIVVPLAALEKAFGPLDTVIVTTLQAISGAGYPGVSSLDIMDNVVPLISGEEDKIEWETNKILGGVTPDNKAFDLHAPKQINVSATCTRVPVIDGHTGCVSVKFARSPPPSVAEVENAFREYTCDAQHLGVPSAPAQAIVVHDAPDRPQPRLDKNLHNGACVSVGRIRECPVFDIKFVCLIDNVRLGAATSSIINAEIAVEKGLIQ

[Multiple Choices]
A. Position 209 (Proton donor)
B. Position 156 (Acyl-thioester intermediate)
C. Position 26 (Proton donor/acceptor)
D. Position 154 (Acyl-thioester intermediate)
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Enzyme Active Site Prediction, which is to identify the key amino acid residues that form the active site of an enzyme. The active site is the specific region on the enzyme where a substrate binds and the chemical reaction is catalyzed. Based on the full protein sequence provided, you must select the option that correctly lists the amino acid residues (by their type and position) that constitute the enzyme's catalytic center.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence-matched UniProt record annotates residue 156 as the acyl-thioester intermediate site. The annotation is computationally assigned by PIRSR, not direct experimental evidence for this specific residue.

Citations as saved: [C5](#evidence-c5), [H4](#evidence-h4).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> Residue 156 in the supplied sequence is cysteine, whereas residue 154 is alanine. A cysteine thiol can form the acyl-thioester intermediate; alanine cannot. This gives a concrete basis to distinguish B from D, and position 26 is leucine, not a plausible proton donor/acceptor.


**Missing item-specific fact**

> No protein-specific active-site annotation is needed to distinguish the listed alternatives on these grounds, though identifying the enzyme family would make the catalytic context clearer.


**Reason**

> The residue identities and the chemistry implied by the choices provide a meaningful sequence-based discriminator; this is more than recalling a database entry or relying on a generic predictor.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Among the options, only position 156 is cysteine and is consistent with the stated acyl-thioester role.


### Important caveats

- The reviewer-only source annotations apply to an exact sequence match, but the active-site annotation carries computational PIRSR evidence rather than direct experimental evidence for residue 156.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "Residue 156 in the supplied sequence is cysteine, whereas residue 154 is alanine. A cysteine thiol can form the acyl-thioester intermediate; alanine cannot. This gives a concrete basis to distinguish B from D, and position 26 is leucine, not a plausible proton donor/acceptor.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "No protein-specific active-site annotation is needed to distinguish the listed alternatives on these grounds, though identifying the enzyme family would make the catalytic context clearer.",
    "reason": "The residue identities and the chemistry implied by the choices provide a meaningful sequence-based discriminator; this is more than recalling a database entry or relying on a generic predictor."
  },
  "case_id": "active_site_0128",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H4"
    ],
    "judgment": "supported",
    "reason": "The sequence-matched UniProt record annotates residue 156 as the acyl-thioester intermediate site. The annotation is computationally assigned by PIRSR, not direct experimental evidence for this specific residue."
  },
  "important_caveats": [
    "The reviewer-only source annotations apply to an exact sequence match, but the active-site annotation carries computational PIRSR evidence rather than direct experimental evidence for residue 156."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the options, only position 156 is cysteine and is consistent with the stated acyl-thioester role."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "active_site_0128",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence-matched UniProt record annotates residue 156 as the acyl-thioester intermediate site. The annotation is computationally assigned by PIRSR, not direct experimental evidence for this specific residue.",
    "evidence_ids": ["C5", "H4"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "Residue 156 in the supplied sequence is cysteine, whereas residue 154 is alanine. A cysteine thiol can form the acyl-thioester intermediate; alanine cannot. This gives a concrete basis to distinguish B from D, and position 26 is leucine, not a plausible proton donor/acceptor.",
    "missing_item_specific_fact": "No protein-specific active-site annotation is needed to distinguish the listed alternatives on these grounds, though identifying the enzyme family would make the catalytic context clearer.",
    "reason": "The residue identities and the chemistry implied by the choices provide a meaningful sequence-based discriminator; this is more than recalling a database entry or relying on a generic predictor."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Among the options, only position 156 is cysteine and is consistent with the stated acyl-thioester role."
  },
  "important_caveats": [
    "The reviewer-only source annotations apply to an exact sequence match, but the active-site annotation carries computational PIRSR evidence rather than direct experimental evidence for residue 156."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt Q5KPK7 (sequence matched, 365 AA) explicitly annotates position 156 as 'Active site: Acyl-thioester intermediate' (evidence C5/H4, ECO:0000255|PIRSR:PIRSR000148-1). The residue at position 156 in the supplied sequence is Cys (C), consistent with the well-established ASADH catalytic mechanism where a conserved cysteine forms the acyl-thioester intermediate. The annotation is PIRSR-derived (computational/curated family signature) rather than direct experimental evidence on this specific protein, but the mechanism is canonical for EC 1.2.1.11 and supported by crystallographic data (PDB 5CEF, PubMed 26527262). The answer is scientifically supported.

Citations as saved: [C5](#evidence-c5), [H4](#evidence-h4), [C4](#evidence-c4), [C18](#evidence-c18), [H3](#evidence-h3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> An acyl-thioester intermediate requires a cysteine thiol; among the four choices, only position 156 encodes Cys (C). Position 154 encodes Ala (A), which cannot form a thioester, eliminating D. Position 26 encodes Leu (L) and position 209 encodes Gly (G); neither has an ionizable side chain capable of proton donation/acceptance, eliminating A and C. The N-terminal Rossmann-fold motif (GATGTVGQ, positions 13–20) and the overall sequence architecture are consistent with an NADP-dependent dehydrogenase, supporting the ASADH catalytic mechanism. Thus, basic amino-acid chemistry and sequence inspection suffice to isolate B.


**Missing item-specific fact**

> None critical. Exact enzyme identity (ASADH, EC 1.2.1.11) aids confirmation but is not strictly required; the thioester-forming requirement uniquely selects Cys, and only position 156 among the choices has Cys.


**Reason**

> The distractors are eliminated by straightforward biochemistry: Ala cannot form a thioester (eliminates D), Leu and Gly lack ionizable side chains for proton transfer (eliminates A and C). The correct residue identity (Cys at 156) is directly readable from the supplied sequence. Recognizing the enzyme as ASADH from the Rossmann-fold motif further corroborates the cysteine-thioester mechanism, but is not strictly necessary to eliminate the other options.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Each distractor is eliminated by a clear biochemical impossibility given the actual amino acid at that position: L at 26 cannot donate/accept a proton, A at 154 cannot form a thioester, G at 209 cannot donate a proton. Only Cys at 156 is chemically consistent with the stated role.


### Important caveats

- The PIRSR annotation (ECO:0000255) is a computational/curated family-signature assignment, not direct experimental evidence on this specific Cryptococcus enzyme, though the ASADH catalytic cysteine mechanism is well-established across the family.
- The UniProt entry was first publicly released in February 2025; the benchmark author's source snapshot is unknown, but the sequence version 1 (2005) and the PIRSR annotation have been stable.
- The actual proton-acceptor active site is annotated at position 255 (His), which is not offered as a choice; the distractors at positions 26 and 209 do not correspond to any annotated active-site residue.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "An acyl-thioester intermediate requires a cysteine thiol; among the four choices, only position 156 encodes Cys (C). Position 154 encodes Ala (A), which cannot form a thioester, eliminating D. Position 26 encodes Leu (L) and position 209 encodes Gly (G); neither has an ionizable side chain capable of proton donation/acceptance, eliminating A and C. The N-terminal Rossmann-fold motif (GATGTVGQ, positions 13–20) and the overall sequence architecture are consistent with an NADP-dependent dehydrogenase, supporting the ASADH catalytic mechanism. Thus, basic amino-acid chemistry and sequence inspection suffice to isolate B.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "None critical. Exact enzyme identity (ASADH, EC 1.2.1.11) aids confirmation but is not strictly required; the thioester-forming requirement uniquely selects Cys, and only position 156 among the choices has Cys.",
    "reason": "The distractors are eliminated by straightforward biochemistry: Ala cannot form a thioester (eliminates D), Leu and Gly lack ionizable side chains for proton transfer (eliminates A and C). The correct residue identity (Cys at 156) is directly readable from the supplied sequence. Recognizing the enzyme as ASADH from the Rossmann-fold motif further corroborates the cysteine-thioester mechanism, but is not strictly necessary to eliminate the other options."
  },
  "case_id": "active_site_0128",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H4",
      "C4",
      "C18",
      "H3"
    ],
    "judgment": "supported",
    "reason": "UniProt Q5KPK7 (sequence matched, 365 AA) explicitly annotates position 156 as 'Active site: Acyl-thioester intermediate' (evidence C5/H4, ECO:0000255|PIRSR:PIRSR000148-1). The residue at position 156 in the supplied sequence is Cys (C), consistent with the well-established ASADH catalytic mechanism where a conserved cysteine forms the acyl-thioester intermediate. The annotation is PIRSR-derived (computational/curated family signature) rather than direct experimental evidence on this specific protein, but the mechanism is canonical for EC 1.2.1.11 and supported by crystallographic data (PDB 5CEF, PubMed 26527262). The answer is scientifically supported."
  },
  "important_caveats": [
    "The PIRSR annotation (ECO:0000255) is a computational/curated family-signature assignment, not direct experimental evidence on this specific Cryptococcus enzyme, though the ASADH catalytic cysteine mechanism is well-established across the family.",
    "The UniProt entry was first publicly released in February 2025; the benchmark author's source snapshot is unknown, but the sequence version 1 (2005) and the PIRSR annotation have been stable.",
    "The actual proton-acceptor active site is annotated at position 255 (His), which is not offered as a choice; the distractors at positions 26 and 209 do not correspond to any annotated active-site residue."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Each distractor is eliminated by a clear biochemical impossibility given the actual amino acid at that position: L at 26 cannot donate/accept a proton, A at 154 cannot form a thioester, G at 209 cannot donate a proton. Only Cys at 156 is chemically consistent with the stated role."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "active_site_0128",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt Q5KPK7 (sequence matched, 365 AA) explicitly annotates position 156 as 'Active site: Acyl-thioester intermediate' (evidence C5/H4, ECO:0000255|PIRSR:PIRSR000148-1). The residue at position 156 in the supplied sequence is Cys (C), consistent with the well-established ASADH catalytic mechanism where a conserved cysteine forms the acyl-thioester intermediate. The annotation is PIRSR-derived (computational/curated family signature) rather than direct experimental evidence on this specific protein, but the mechanism is canonical for EC 1.2.1.11 and supported by crystallographic data (PDB 5CEF, PubMed 26527262). The answer is scientifically supported.",
    "evidence_ids": ["C5", "H4", "C4", "C18", "H3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "An acyl-thioester intermediate requires a cysteine thiol; among the four choices, only position 156 encodes Cys (C). Position 154 encodes Ala (A), which cannot form a thioester, eliminating D. Position 26 encodes Leu (L) and position 209 encodes Gly (G); neither has an ionizable side chain capable of proton donation/acceptance, eliminating A and C. The N-terminal Rossmann-fold motif (GATGTVGQ, positions 13–20) and the overall sequence architecture are consistent with an NADP-dependent dehydrogenase, supporting the ASADH catalytic mechanism. Thus, basic amino-acid chemistry and sequence inspection suffice to isolate B.",
    "missing_item_specific_fact": "None critical. Exact enzyme identity (ASADH, EC 1.2.1.11) aids confirmation but is not strictly required; the thioester-forming requirement uniquely selects Cys, and only position 156 among the choices has Cys.",
    "reason": "The distractors are eliminated by straightforward biochemistry: Ala cannot form a thioester (eliminates D), Leu and Gly lack ionizable side chains for proton transfer (eliminates A and C). The correct residue identity (Cys at 156) is directly readable from the supplied sequence. Recognizing the enzyme as ASADH from the Rossmann-fold motif further corroborates the cysteine-thioester mechanism, but is not strictly necessary to eliminate the other options."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Each distractor is eliminated by a clear biochemical impossibility given the actual amino acid at that position: L at 26 cannot donate/accept a proton, A at 154 cannot form a thioester, G at 209 cannot donate a proton. Only Cys at 156 is chemically consistent with the stated role."
  },
  "important_caveats": [
    "The PIRSR annotation (ECO:0000255) is a computational/curated family-signature assignment, not direct experimental evidence on this specific Cryptococcus enzyme, though the ASADH catalytic cysteine mechanism is well-established across the family.",
    "The UniProt entry was first publicly released in February 2025; the benchmark author's source snapshot is unknown, but the sequence version 1 (2005) and the PIRSR annotation have been stable.",
    "The actual proton-acceptor active site is annotated at position 255 (His), which is not offered as a choice; the distractors at positions 26 and 209 do not correspond to any annotated active-site residue."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `Q5KPK7` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 121. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q5KPK7.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:31:24.745599+00:00.  

```json
{"recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"26527262","source":"PubMed"},{"evidenceCode":"ECO:0000269","id":"29608391","source":"PubMed"}],"value":"1.2.1.11"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000305"}],"value":"Aspartate-semialdehyde dehydrogenase"}}}
```

Source SHA-256: `6e1b51beba0452942e5c6cb2774ea67654b44f73f1d91b259ec7240bea1d2e67`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q5KPK7.json)  
**Locator:** `/features/1`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:31:24.745599+00:00.  

```json
{"description":"Acyl-thioester intermediate","evidences":[{"evidenceCode":"ECO:0000255","id":"PIRSR000148-1","source":"PIRSR"}],"location":{"end":{"modifier":"EXACT","value":156},"start":{"modifier":"EXACT","value":156}},"type":"Active site"}
```

Source SHA-256: `6e1b51beba0452942e5c6cb2774ea67654b44f73f1d91b259ec7240bea1d2e67`.

### Evidence C18

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/Q5KPK7.json)  
**Locator:** `/references/3`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:31:24.745599+00:00.  

```json
{"citation":{"authors":["Dahal G.","Viola R.E."],"citationCrossReferences":[{"database":"PubMed","id":"26527262"},{"database":"DOI","id":"10.1107/s2053230x15017495"}],"citationType":"journal article","firstPage":"1365","id":"26527262","journal":"Acta Crystallogr. F Struct. Biol. Commun.","lastPage":"1371","publicationDate":"2015","title":"Structure of a fungal form of aspartate semialdehyde dehydrogenase from Cryptococcus neoformans.","volume":"71"},"evidences":[{"evidenceCode":"ECO:0007744","id":"5CEF","source":"PDB"}],"referenceNumber":4,"referencePositions":["X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS)","FUNCTION","CATALYTIC ACTIVITY","BIOPHYSICOCHEMICAL PROPERTIES","PATHWAY","SUBUNIT"]}
```

Source SHA-256: `6e1b51beba0452942e5c6cb2774ea67654b44f73f1d91b259ec7240bea1d2e67`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/Q5KPK7?format=txt&versions=121)  
**Locator:** `lines 46-53`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 121 / 1.  
**Retrieved:** 2026-11-02T04:31:27.262588+00:00.  

```text
RN   [4] {ECO:0007744|PDB:5CEF}
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS), FUNCTION, CATALYTIC ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, PATHWAY, AND SUBUNIT.
RX   PubMed=26527262; DOI=10.1107/s2053230x15017495;
RA   Dahal G., Viola R.E.;
RT   "Structure of a fungal form of aspartate semialdehyde dehydrogenase from
RT   Cryptococcus neoformans.";
RL   Acta Crystallogr. F Struct. Biol. Commun. 71:1365-1371(2015).
```

Source SHA-256: `117184b77b1c1a6b186665d7a7a3070affc905fd69df2a927a14fb0e3ceb88c4`.

### Evidence H4

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/Q5KPK7?format=txt&versions=121)  
**Locator:** `lines 158-160`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 121 / 1.  
**Retrieved:** 2026-11-02T04:31:27.262588+00:00.  

```text
FT   ACT_SITE        156
FT                   /note="Acyl-thioester intermediate"
FT                   /evidence="ECO:0000255|PIRSR:PIRSR000148-1"
```

Source SHA-256: `117184b77b1c1a6b186665d7a7a3070affc905fd69df2a927a14fb0e3ceb88c4`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/active_site.json), zero-based source row 128. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
